Skip to main content
HUMANA INC logo

HUMANA INC — Investor Relations & Filings

Ticker · HUM ISIN · US4448591028 LEI · 529900YLDW34GJAO4J06 US Financial and insurance activities
Open in API
Filings indexed 3,056 across all filing types
Latest filing 2017-06-19 Capital/Financing Update
Country US United States of America
Listing US HUM

About HUMANA INC

https://www.humana.com/

Humana Inc. is a health and well-being company offering a broad range of health insurance products and healthcare services. The company primarily focuses on providing Medicare plans, including Medicare Advantage and Prescription Drug Plans (Part D), to eligible individuals. Beyond its Medicare offerings, Humana provides other medical and specialty insurance products. The company operates through two main segments: Insurance, which encompasses its health plans, and CenterWell, which delivers healthcare services such as primary care, pharmacy operations, and in-home care. Humana is committed to a personalized and simplified whole-person healthcare approach, aiming to help its members achieve better health outcomes through integrated care and wellness solutions.

Recent filings

Filing Released Lang Actions
HUMANA INC. FORM 8-K 06-15-2017
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed by Humana Inc. dated June 19, 2017. The content describes an increase in the size of the company's commercial paper program from $1.0 billion to $2.0 billion. This is an update on the company's financing activities, specifically related to its commercial paper program. The document does not contain financial statements or detailed financial analysis but rather an announcement of a capital/financing update. The length is 3635 characters, which is relatively short but contains substantive information about financing changes, not just a report publication announcement or certification. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2017-06-19 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-06 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes a Regulation FD Disclosure about management meetings with investors and reaffirmation of earnings guidance for the fiscal year ending December 31, 2017. It provides adjusted EPS guidance and a reconciliation to GAAP EPS. The document is relatively short (4604 characters) and does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). Instead, it is an announcement of updated financial guidance and investor communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2017-06-05 English
PRIMARY DOCUMENT
Director's Dealing
2017-05-30 English
FORM 144 HSM 05/26/2017
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of restricted stock by a senior executive of Humana Inc. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to insider transactions. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement.
2017-05-26 English
HUM FORM 8-K 05-22-2017
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the entry into a material definitive agreement, namely an amended and restated five-year $2 billion unsecured revolving credit agreement. It also discusses the termination of the previous credit agreement and the creation of a direct financial obligation. The focus is on financing activities and credit agreements, which aligns with updates on company fundraising or capital structure changes. The document is not a full financial report, earnings release, or management discussion, but rather a regulatory filing announcing a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2017-05-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.